LOS ANGELES CAPITAL MANAGEMENT LLC - ARIAD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$107,000
-94.0%
14,545
-85.0%
0.00%
-95.5%
Q3 2013$1,780,000
+23.4%
96,755
+17.2%
0.02%
+10.0%
Q2 2013$1,443,00082,5250.02%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$175,916,00040.51%
Consonance Capital Management LP 8,695,742$119,045,00011.46%
Tamarack Advisers, LP 3,700,000$49,358,0007.76%
Opaleye Management Inc. 1,045,000$14,306,0007.49%
Granite Point Capital Management, L.P. 457,415$6,262,0002.44%
Redmile Group, LLC 2,138,471$29,276,0002.33%
IRONWOOD INVESTMENT MANAGEMENT LLC 206,010$2,820,0002.17%
Palo Alto Investors LP 2,587,617$35,424,0002.06%
PRICE MICHAEL F 940,000$12,869,0001.71%
HighVista Strategies LLC 638,086$8,735,0001.62%
View complete list of ARIAD PHARMACEUTICALS INC shareholders